MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

S Saadatmand; Amarens Geuzinge; EJT Rutgers; RM Mann; D van Zuidewijn; HM Zonderland; R Tollenaar; MBI Lobbes; M Ausems; M van t'Riet; Maartje Hooning; I Mares-Engelberts; EJT Luiten; Eveline Heijnsdijk; Kees Verhoef; N Karssemeijer; JC Oosterwijk; Inge-marie Obdeijn; Harry de Koning; MMA Tilanus-Linthorst

doi:10.1016/s1470-2045(19)30275-x

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

S Saadatmand
, Amarens Geuzinge
, EJT Rutgers
, RM Mann
, D van Zuidewijn
, HM Zonderland
, R Tollenaar
, MBI Lobbes
, M Ausems
, M van t'Riet
, Maartje Hooning
, I Mares-Engelberts
, EJT Luiten
, Eveline Heijnsdijk
, Kees Verhoef
, N Karssemeijer
, JC Oosterwijk
, Inge-marie Obdeijn
, Harry de Koning
, MMA Tilanus-Linthorst

Research output: Contribution to journal › Article › Academic › peer-review

166 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1136-1147
Number of pages	12
Journal	Lancet Oncology
Volume	20
Issue number	8
DOIs	https://doi.org/10.1016/s1470-2045(19)30275-x
Publication status	Published - 2019

Research programs

EMC MM-03-47-11
EMC MM-03-86-01
EMC NIHES-02-65-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s1470-2045(19)30275-x

http://hdl.handle.net/1765/118984

Cite this

Saadatmand, S., Geuzinge, A., Rutgers, EJT., Mann, RM., van Zuidewijn, D., Zonderland, HM., Tollenaar, R., Lobbes, MBI., Ausems, M., van t'Riet, M., Hooning, M., Mares-Engelberts, I., Luiten, EJT., Heijnsdijk, E., Verhoef, K., Karssemeijer, N., Oosterwijk, JC., Obdeijn, I., de Koning, H., & Tilanus-Linthorst, MMA. (2019). MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial. Lancet Oncology, 20(8), 1136-1147. https://doi.org/10.1016/s1470-2045(19)30275-x

@article{87a6de3eccb342f8b7716e7455f40d7b,

title = "MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial",

author = "S Saadatmand and Amarens Geuzinge and EJT Rutgers and RM Mann and \{van Zuidewijn\}, D and HM Zonderland and R Tollenaar and MBI Lobbes and M Ausems and \{van t'Riet\}, M and Maartje Hooning and I Mares-Engelberts and EJT Luiten and Eveline Heijnsdijk and Kees Verhoef and N Karssemeijer and JC Oosterwijk and Inge-marie Obdeijn and \{de Koning\}, Harry and MMA Tilanus-Linthorst",

year = "2019",

doi = "10.1016/s1470-2045(19)30275-x",

language = "Undefined/Unknown",

volume = "20",

pages = "1136--1147",

journal = "Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "8",

}

Saadatmand, S, Geuzinge, A, Rutgers, EJT, Mann, RM, van Zuidewijn, D, Zonderland, HM, Tollenaar, R, Lobbes, MBI, Ausems, M, van t'Riet, M, Hooning, M, Mares-Engelberts, I, Luiten, EJT, Heijnsdijk, E , Verhoef, K, Karssemeijer, N, Oosterwijk, JC, Obdeijn, I, de Koning, H & Tilanus-Linthorst, MMA 2019, 'MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial', Lancet Oncology, vol. 20, no. 8, pp. 1136-1147. https://doi.org/10.1016/s1470-2045(19)30275-x

TY - JOUR

T1 - MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

AU - Saadatmand, S

AU - Geuzinge, Amarens

AU - Rutgers, EJT

AU - Mann, RM

AU - van Zuidewijn, D

AU - Zonderland, HM

AU - Tollenaar, R

AU - Lobbes, MBI

AU - Ausems, M

AU - van t'Riet, M

AU - Hooning, Maartje

AU - Mares-Engelberts, I

AU - Luiten, EJT

AU - Heijnsdijk, Eveline

AU - Verhoef, Kees

AU - Karssemeijer, N

AU - Oosterwijk, JC

AU - Obdeijn, Inge-marie

AU - de Koning, Harry

AU - Tilanus-Linthorst, MMA

PY - 2019

Y1 - 2019

U2 - 10.1016/s1470-2045(19)30275-x

DO - 10.1016/s1470-2045(19)30275-x

M3 - Article

SN - 1470-2045

VL - 20

SP - 1136

EP - 1147

JO - Lancet Oncology

JF - Lancet Oncology

IS - 8

ER -